Article
Skin ECM Provides a Bio-Derived Platform for Supporting Dermal Renewal and Matrix Synthesis
17 Jun 2025
Abstract excerpt
subcutaneous implantation confirms high local and systemic biocompatibility without signs of inflammation or toxicity. Collectively, these findings establish Skin ECM as a bioactive, tissue-specific, and immunologically compatible ECM material, offering broad utility in regenerative medicine, three-dimensional (3D) skin model systems, and dermal therapeutics including cosmetic interventions.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
